APA Alıntı

Gupta, R. (2020). Pharmacovigilance of biosimilars - Why is it different from generics and innovator biologics? J Postgrad Med.

Chicago Stili Alıntı

Gupta, Ranjan. "Pharmacovigilance of Biosimilars - Why Is It Different From Generics and Innovator Biologics?" J Postgrad Med 2020.

MLA Alıntı

Gupta, Ranjan. "Pharmacovigilance of Biosimilars - Why Is It Different From Generics and Innovator Biologics?" J Postgrad Med 2020.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..